Growth Metrics

Legend Biotech (LEGN) Capital Leases (2023 - 2024)

Legend Biotech filings provide 2 years of Capital Leases readings, the most recent being $45.6 million for Q3 2024.

  • On a quarterly basis, Capital Leases rose 209.45% to $45.6 million in Q3 2024 year-over-year; TTM through Sep 2024 was $45.6 million, a 209.45% increase, with the full-year FY2023 number at $44.2 million, changed N/A from a year prior.
  • Capital Leases hit $45.6 million in Q3 2024 for Legend Biotech, up from $44.0 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $45.6 million in Q3 2024 to a low of -$44.4 million in Q2 2023.